Vertex Pharmaceuticals Incorporated Share Price Sao Paulo
Stocks
VRTX34
BRVRTXBDR001
Pharmaceuticals
|
Delayed
Sao Paulo
06:31:00 18/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 81.61 BRL | -85.92% |
|
-4.21% | +4.31% |
| 12/08 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 11/08 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
| Market Cap | 13TCr 68TCr 11TCr 11TCr 9.64TCr 18TCr 12,49400Cr 18TCr 1,24100Cr 49TCr 6,25900Cr 49TCr 48TCr 20,82200Cr | P/E 2026 * |
30.4x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 12TCr 60TCr 10TCr 9.43TCr 8.59TCr 16TCr 11,13200Cr 16TCr 1,10500Cr 43TCr 5,57700Cr 44TCr 43TCr 18,55300Cr | EV / Sales 2026 * |
8.83x | EV / Sales 2027 * | 7.7x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -85.92% | ||
| 1 week | -4.21% | ||
| Current month | +5.81% | ||
| 1 month | +5.82% | ||
| 3 months | +19.29% | ||
| 6 months | +5.73% | ||
| Current year | +4.31% |
| 1 week | 81.61 |  | 84.96 |
| 1 month | 74.56 | | 85.52 |
| Current year | 65.18 | | 86.31 |
| 1 year | 62.2 | | 86.31 |
| 3 years | 52.29 | | 93.56 |
| 5 years | 30.22 | | 93.56 |
| 10 years | 20.29 | | 93.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 10/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -85.92% | -4.21% | - | - | 13TCr | |
| +2.41% | -0.17% | +73.76% | +121.97% | 1,05500Cr | |
| +2.76% | +3.74% | +52.92% | +56.25% | 63TCr | |
| +2.42% | +2.74% | +24.38% | +71.13% | 44TCr | |
| +1.14% | -2.55% | +40.43% | +40.95% | 35TCr | |
| +1.70% | -0.35% | +25.14% | +40.31% | 29TCr | |
| +1.89% | -0.64% | +0.26% | +10.41% | 24TCr | |
| +1.24% | +2.46% | +45.07% | +62.14% | 23TCr | |
| +1.05% | -3.87% | -15.02% | -52.80% | 20TCr | |
| +2.37% | +4.53% | +20.28% | +87.03% | 17TCr | |
| Average | -6.89% | -1.44% | +29.69% | +48.60% | 40.14TCr | |
| Weighted average by Cap. | -0.96% | -1.87% | +42.71% | +67.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.32TCr 6.84TCr 1.14TCr 1.07TCr 972.96Cr 1.83TCr 1,26100Cr 1.85TCr 13TCr 4.91TCr 63TCr 4.95TCr 4.84TCr 2,10200Cr | 1.46TCr 7.56TCr 1.26TCr 1.18TCr 1.08TCr 2.02TCr 1,39400Cr 2.05TCr 14TCr 5.43TCr 70TCr 5.48TCr 5.36TCr 2,32400Cr |
| Net income | 430.55Cr 2.23TCr 371.69Cr 348.71Cr 317.61Cr 597.2Cr 41TCr 605.48Cr 4.09TCr 1.6TCr 21TCr 1.62TCr 1.58TCr 69TCr | 521.76Cr 2.7TCr 450.43Cr 422.57Cr 384.89Cr 723.71Cr 50TCr 733.74Cr 4.95TCr 1.94TCr 25TCr 1.96TCr 1.92TCr 83TCr |
| Net Debt | -1.42TCr -7.38TCr -1.23TCr -1.15TCr -1.05TCr -1.98TCr -1,36200Cr -2TCr -14TCr -5.3TCr -68TCr -5.35TCr -5.23TCr -2,26900Cr | -1.84TCr -9.56TCr -1.59TCr -1.49TCr -1.36TCr -2.56TCr -1,76300Cr -2.59TCr -18TCr -6.86TCr -88TCr -6.92TCr -6.77TCr -2,93800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | R$81.61 | -85.92% | 56 |
| 14/26/14 | R$83.28 | -1.87% | 112 |
| 12/26/12 | R$84.87 | -0.39% | 4 |
| 11/26/11 | R$85.20 | +2.49% | 901 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
Select your edition
All financial news and data tailored to specific country editions
